Centre of Biosciences of the Slovak Academy of Sciences, Institute of Animal Physiology, Šoltésovej 4-6, 040 01, Košice, Slovakia.
University of Veterinary Medicine and Pharmacy in Košice, Clinic of Horses and Department of Microbiology and Imunology, Komenského 73, 041 81, Košice, Slovakia.
Vet Res Commun. 2023 Sep;47(3):1471-1478. doi: 10.1007/s11259-023-10101-5. Epub 2023 Mar 16.
Nowadays, developed more precisious identification techniques have allowed to validate newer enterococcal species. Among them, the species Enterococcus moraviensis was also validated, at first from surface waters. However, in this study, characteristics and potential to bacteriocin production by the strain E. moraviensis EMo 1-1Nik isolated from buccal mucosa of Slovak warm-blood horse breed has been studied. BLASTn analysis allotted this strain to the species E. moraviensis with percentage identity BLASTn 16S rRNA sequence in the strain up to 100% (99.93% similarity with E. moraviensis NR113937.1). The strain EMo 1-1Nik has been provided with GenBank accession number MW326085. It is hemolysis-negative (γ-hemolysis), deoxyribonuclease-negative and gelatinase-negative; absent of virulence factor genes, low-grade biofilm-positive (0.133 ± 0.36), mostly susceptible to tested antibiotics. Moreover, 60% of EMo1-1Nik colonies were found as bacteriocin-producing against the principal indicator Enterococcus avium EA5. The concentrated substance (CS, pH 4.5) of EMo1-1Nik showed the inhibitory activity against EA5 strain (800 AU/mL); CSs with pH 6.3 and 7.3 reached inhibitory activity 100 AU/mL against EA5 strain. CS was thermo-stable and it does not lost activity after enzymes treatment. Oppositelly, EMo 1-1Nik was susceptible to Mundticin EM 41/3 (800 AU/mL) produced by horse fecal strain E. mundtii EM 41/3 and enterocins (up to 51 200 AU/mL). In spite of the preliminary results, it has been shown a potential to produce bacteriocin substance of the safe strain E. moraviensis EMo1-1Nik. The additional studies are in processing.
如今,更精确的鉴定技术已经能够验证新的肠球菌物种。其中,肠球菌摩拉维亚亚种也得到了验证,最初是从地表水开始的。然而,在这项研究中,从斯洛伐克温血马口腔黏膜中分离出的肠球菌摩拉维亚亚种 EMo 1-1Nik 菌株的特征和生产细菌素的潜力得到了研究。BLASTn 分析将该菌株分配到肠球菌摩拉维亚亚种,其 16S rRNA 序列的 BLASTn 百分比同一性为 100%(与 E. moraviensis NR113937.1 的相似度为 99.93%)。菌株 EMo 1-1Nik 已获得 GenBank 登录号 MW326085。它是溶血阴性(γ-溶血)、脱氧核糖核酸酶阴性和明胶酶阴性;不存在毒力因子基因,低水平生物膜阳性(0.133±0.36),对测试的抗生素大多敏感。此外,发现 60%的 EMo1-1Nik 菌落对主要指示菌鸡肠球菌 EA5 具有细菌素产生能力。浓缩物质(CS,pH4.5)对 EA5 菌株具有抑制活性(800 AU/mL);pH6.3 和 7.3 的 CSs 对 EA5 菌株的抑制活性为 100 AU/mL。CS 热稳定,经酶处理后不会失去活性。相反,EMo 1-1Nik 对马粪便菌株 E. mundtii EM 41/3 产生的 mundticin EM 41/3 和肠球菌(高达 51 200 AU/mL)敏感。尽管初步结果表明,安全菌株 E. moraviensis EMo1-1Nik 具有产生细菌素物质的潜力。正在进行进一步的研究。